Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-18 4:30 pm Purchase | 2025-11-11 | 13G | Vor Biopharma Inc. VOR | Paradigm BioCapital Advisors LP | 1,750,000 8.600% | 1,750,000![]() (New Position) | Filing History |
| 2025-11-14 4:34 pm Sale | 2025-09-30 | 13G | Cogent Biosciences, Inc. COGT | Paradigm BioCapital Advisors LP | 3,156,398 2.300% | -7,196,051![]() (-69.51%) | Filing History |
| 2025-11-14 4:34 pm Sale | 2025-09-30 | 13G | Agios Pharmaceuticals, Inc. AGIO | Paradigm BioCapital Advisors LP | 2,873,555 4.900% | -154,422![]() (-5.10%) | Filing History |
| 2025-11-14 4:34 pm Sale | 2025-09-30 | 13G | Cidara Therapeutics, Inc. CDTX | Paradigm BioCapital Advisors LP | 961,164 3.300% | -167,449![]() (-14.84%) | Filing History |
| 2025-11-14 4:32 pm Sale | 2025-09-30 | 13G | LENZ Therapeutics, Inc. LENZ | Paradigm BioCapital Advisors LP | 1,073,461 3.800% | -346,371![]() (-24.40%) | Filing History |
| 2025-11-14 4:32 pm Purchase | 2025-09-30 | 13G | Merus N.V. MRUS | Paradigm BioCapital Advisors LP | 4,673,770 6.200% | 1,119,711![]() (+31.51%) | Filing History |
| 2025-11-14 4:31 pm Purchase | 2025-09-30 | 13G | UroGen Pharma Ltd. URGN | Paradigm BioCapital Advisors LP | 4,216,084 9.000% | 1,884,018![]() (+80.79%) | Filing History |
| 2025-11-14 4:31 pm Sale | 2025-09-30 | 13G | Y-mAbs Therapeutics, Inc. YMAB | Paradigm BioCapital Advisors LP | 0 0.000% | -4,086,346![]() (Position Closed) | Filing History |
| 2025-08-28 4:31 pm Purchase | 2025-08-21 | 13G | Agios Pharmaceuticals, Inc. AGIO | Paradigm BioCapital Advisors LP | 3,027,977 5.200% | 3,027,977![]() (New Position) | Filing History |
| 2025-08-14 4:31 pm Purchase | 2025-06-30 | 13G | Cogent Biosciences, Inc. COGT | Paradigm BioCapital Advisors LP | 10,352,449 9.100% | 1,388,794![]() (+15.49%) | Filing History |
| 2025-08-14 4:31 pm Sale | 2025-06-30 | 13G | Janux Therapeutics, Inc. JANX | Paradigm BioCapital Advisors LP | 2,920,258 4.900% | -595,728![]() (-16.94%) | Filing History |
| 2025-08-12 4:30 pm Purchase | 2025-08-05 | 13G | UroGen Pharma Ltd. URGN | Paradigm BioCapital Advisors LP | 2,332,066 5.000% | 2,332,066![]() (New Position) | Filing History |
| 2025-07-30 4:14 pm Purchase | 2025-07-23 | 13G | Cidara Therapeutics, Inc. CDTX | Paradigm BioCapital Advisors LP | 1,128,613 5.600% | 1,128,613![]() (New Position) | Filing History |
| 2025-05-15 4:40 pm Sale | 2025-03-31 | 13G | Disc Medicine, Inc. IRON | Paradigm BioCapital Advisors LP | 1,210,971 3.500% | -286,749![]() (-19.15%) | Filing History |
| 2025-05-15 4:39 pm Sale | 2025-03-31 | 13G | Pliant Therapeutics, Inc. PLRX | Paradigm BioCapital Advisors LP | 0 0.000% | -3,059,411![]() (Position Closed) | Filing History |
| 2025-05-15 4:39 pm Purchase | 2025-03-31 | 13G | Cogent Biosciences, Inc. COGT | Paradigm BioCapital Advisors LP | 8,963,655 7.900% | 3,403,731![]() (+61.22%) | Filing History |
| 2025-04-10 4:19 pm Purchase | 2025-04-03 | 13G | Merus N.V. MRUS | Paradigm BioCapital Advisors LP | 3,554,059 5.100% | 3,554,059![]() (New Position) | Filing History |
| 2025-03-27 4:21 pm Purchase | 2025-03-20 | 13G | LENZ Therapeutics, Inc. LENZ | Paradigm BioCapital Advisors LP | 1,419,832 5.200% | 1,419,832![]() (New Position) | Filing History |
| 2025-02-14 4:45 pm Purchase | 2024-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA | Paradigm BioCapital Advisors LP | 7,429,355 9.990% | 1,925,755![]() (+34.99%) | Filing History |
| 2025-02-14 4:42 pm Sale | 2024-12-31 | 13G | Kura Oncology, Inc. KURA | Paradigm BioCapital Advisors LP | 0 0.000% | -4,331,321![]() (Position Closed) | Filing History |

